Recombinant Human PRH1 Protein，His

PRH1 (Positive Regulatory Domain I-Binding Protein 1) is a member of the PRH/Hex family of transcription factors, which play essential roles in various biological processes, including cell differentiation, proliferation, and apoptosis. The study of PRH1 has gained attention due to its involvement in several diseases, particularly its regulatory functions in hematopoiesis and immune responses. Researchers have identified that PRH1 can modulate gene expression by interacting with other proteins and DNA elements, affecting cellular outcomes. Its dysregulation has been linked to disorders such as leukemia and other malignancies, highlighting its potential as a therapeutic target. To better understand PRH1's functions and mechanisms, scientists have focused on the development of recombinant PRH1 proteins. These recombinant proteins are crucial for elucidating PRH1’s structure-function relationships and its interactions with other cellular components. Utilizing techniques such as recombinant DNA technology, researchers can produce PRH1 in sufficient quantities for biochemical and biophysical analyses. This research not only enhances our understanding of PRH1's role in normal cellular physiology but also provides insights into its pathological implications, paving the way for the development of novel therapeutic strategies targeting PRH1 in related diseases. Overall, the study of PRH1 recombinant proteins represents a significant step forward in elucidating the complex regulatory networks involving this critical transcription factor.